Agreed re looking at NPAT and getting concerned on the decrease. The market certainly looked through that and wasn't phased. Nice pullback recent days providing an opportunity to top up. I'm looking for CUV to push back to re-test $20.50 again from here.
- Forums
- ASX - By Stock
- CUV
- Ann: Appendix 4E and Annual Report 2022
CUV
clinuvel pharmaceuticals limited
Add to My Watchlist
1.84%
!
$10.16

Ann: Appendix 4E and Annual Report 2022, page-5
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$10.16 |
Change
-0.190(1.84%) |
Mkt cap ! $509.2M |
Open | High | Low | Value | Volume |
$10.35 | $10.44 | $10.15 | $621.4K | 60.52K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2039 | $10.16 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$10.17 | 124 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1094 | 10.150 |
1 | 2000 | 10.140 |
1 | 110 | 10.100 |
1 | 1000 | 10.090 |
1 | 1000 | 10.080 |
Price($) | Vol. | No. |
---|---|---|
10.200 | 1995 | 1 |
10.290 | 30 | 1 |
10.500 | 100 | 1 |
10.570 | 1000 | 1 |
10.600 | 100 | 1 |
Last trade - 16.13pm 04/07/2025 (20 minute delay) ? |
Featured News
CUV (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online